Digital
EUHUBS4DATA
The aim of EUHUBS4DATA is to create a federation of reference in Europe for cross-border Big Data experimentation and innovation.


Project dates
2026-2031
Website
Role of Zabala
Partner
Project led by
King’s College London & GE Healthcare
62
Partners
25
Countries
€50. 4 M
Total budget
60
Months
Cardiotoxicity is a growing and often under-detected consequence of modern cancer therapies, with significant implications for patient survival, quality of life and healthcare systems. Current tools have limited predictive value and there is a lack of reliable biomarkers, meaning cardiovascular complications are often detected too late. At the same time, fragmentation between oncology and cardiology, together with challenges in data integration, hinders timely diagnosis, coordinated care and effective long-term patient monitoring.
COMPASS addresses these challenges by developing a comprehensive, patient-centred clinical pathway to improve the cardiovascular health of cancer patients and survivors. By integrating advanced diagnostics, novel biomarkers, real-world data and AI-driven analytics, the project enables earlier detection of cardiotoxicity, supports personalised treatment decisions, and facilitates continuous patient monitoring.
COMPASS will deliver significant scientific, economic and societal impact by developing novel biomarkers, large-scale datasets and validated artificial intelligence models to advance research in cardio-oncology. The project will contribute to improving healthcare system efficiency by supporting the development of cost-effective, evidence-based care pathways that are integrated and harmonised across Europe. In addition, it will enhance the quality of life of cancer patients and survivors through earlier detection, more personalised care and improved long-term cardiovascular outcomes.
COMPASS is an ambitious project supported by the Innovative Health Initiative (IHI JU), bringing together 62 international partners from 25 countries. Its aim is to improve cardiovascular health among cancer patients and survivors by developing a patient-centred cardio-oncology care pathway supported by novel biomarkers, clinical data and artificial intelligence. Full list of consortium partners.


This project is supported by the Innovative Health Initiative Joint Undertaking (IHI JU) under grant agreement 101253264. The JU receives support from the European Union’s Horizon Europe research and innovation programme and COCIR, EFPIA, Europa Bío, MedTech Europe, Vaccines Europe, and ECG Médica S.L. (Ascires).

“COMPASS brings together cutting-edge science, digital innovation and multidisciplinary collaboration to transform the way cardiovascular risks are managed in cancer care, enabling more proactive, personalised and equitable healthcare for patients across Europe.”
Laura Sesma
Team leader expert in European Programmes in the Health Area
Digital
The aim of EUHUBS4DATA is to create a federation of reference in Europe for cross-border Big Data experimentation and innovation.
Energy
EDWIM aims to develop and demonstrate innovative manufacturing solutions for two of the most critical elements of modern wind turbines:...
Energy
sCO2-FLEX will contribute to Europe's climate change and energy transition goals.

News
MSCA DN
The new framework changes the evaluation process, scientific panel allocation, secondments and funding, and introduces an artificial intelligence pilot

Opinion
EUROPEAN COMMISSION

Daniel García
Head of Seville office

Publication
European Programmes
We have gathered the most relevant European Programmes calls for proposals in a calendar until July 2027, available for download!
Lo importante no es seguir avanzando, sino saber hacia dónde ir. Y nuestra tasa de éxito del 37% demuestra que en Zabala sabemos guiar a nuestros clientes.
Nuestra brújula es el cliente; nuestra misión es resolver sus problemas, guiándole para que la innovación se convierta en su clave de competitividad.
